These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17517054)

  • 21. Vincristine induced apoptosis in acute lymphoblastic leukaemia cells: a mitochondrial controlled pathway regulated by reactive oxygen species?
    Groninger E; Meeuwsen-De Boer GJ; De Graaf SS; Kamps WA; De Bont ES
    Int J Oncol; 2002 Dec; 21(6):1339-45. PubMed ID: 12429986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulator activity of PSC 833 and cyclosporin-A in vincristine and doxorubicin-selected multidrug resistant murine leukemic cells.
    Lopes EC; Scolnik M; Alvarez E; Hajos SE
    Leuk Res; 2001 Jan; 25(1):85-93. PubMed ID: 11137565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells.
    Parekh H; Simpkins H
    Cancer Chemother Pharmacol; 1996; 37(5):457-62. PubMed ID: 8599869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. STI571 combined with vincristine greatly suppressed the tumor formation of multidrug-resistant K562 cells in a human-nude mice xenograft model.
    Gao L; Chen L; Fei XH; Qiu HY; Zhou H; Wang JM
    Chin Med J (Engl); 2006 Jun; 119(11):911-8. PubMed ID: 16780770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines.
    van der Graaf WT; de Vries EG; Timmer-Bosscha H; Meersma GJ; Mesander G; Vellenga E; Mulder NH
    Cancer Res; 1994 Oct; 54(20):5368-73. PubMed ID: 7923167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of autophagy sensitizes MDR-phenotype ovarian cancer SKVCR cells to chemotherapy.
    Liang B; Liu X; Liu Y; Kong D; Liu X; Zhong R; Ma S
    Biomed Pharmacother; 2016 Aug; 82():98-105. PubMed ID: 27470344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR.
    Yang YX; Xiao ZQ; Chen ZC; Zhang GY; Yi H; Zhang PF; Li JL; Zhu G
    Proteomics; 2006 Mar; 6(6):2009-21. PubMed ID: 16525997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BATF2 inhibits chemotherapy resistance by suppressing AP-1 in vincristine-resistant gastric cancer cells.
    Yang W; Zhao S; Wu B; Xu J; Wu Z; Guo J; Zeng R
    Cancer Chemother Pharmacol; 2019 Dec; 84(6):1279-1288. PubMed ID: 31549215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between permeability-related glycoprotein expression and susceptibilty to oxygen radicals in vincristine-resistant hematologic cell lines.
    Hirose M; Hamano S; Hosoi E; Kuroda Y
    Cancer Lett; 1997 Dec; 120(2):179-84. PubMed ID: 9461035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal effect of bufalin on multidrug resistance in K562/VCR vincristine-resistant leukemia cell line.
    Zhai X; Lu J; Wang Y; Fang F; Li B; Gu W
    J Tradit Chin Med; 2014 Dec; 34(6):678-83. PubMed ID: 25618972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyramidatine (Z88) Sensitizes Vincristine-Resistant Human Oral Cancer (KB/VCR) Cells to Chemotherapeutic Agents by Inhibition of P-glycoprotein.
    Liu Z; Zhu H; Qu S; Tang L; Cao L; Yu W; Yang X; Jiang S; Zhu D; Tan C; Yu L
    Anticancer Agents Med Chem; 2018; 18(2):286-294. PubMed ID: 28782465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic activity of several unrelated drugs on L1210 mouse leukemic cell sublines with P-glycoprotein (PGP) mediated multidrug resistance (MDR) phenotype. A QSAR study.
    Breier A; Drobná Z; Docolomansky P; Barancik M
    Neoplasma; 2000; 47(2):100-6. PubMed ID: 10985475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Up-regulation of GLI1 in vincristine-resistant rhabdomyosarcoma and Ewing sarcoma.
    Yoon JW; Lamm M; Chandler C; Iannaccone P; Walterhouse D
    BMC Cancer; 2020 Jun; 20(1):511. PubMed ID: 32493277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance.
    Li G; Hu X; Sun L; Li X; Li J; Li T; Zhang X
    Cell Mol Biol Lett; 2018; 23():6. PubMed ID: 29483928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic effect of cyclosporin A and verapamil in overcoming vincristine resistance of multidrug-resistant cultured human leukemia cells.
    Ishida Y; Shimada Y; Shimoyama M
    Jpn J Cancer Res; 1990 Aug; 81(8):834-41. PubMed ID: 2118896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
    Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
    Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and molecular cloning of human sorcin a calcium-binding protein in vincristine-resistant HOB1 lymphoma cells.
    Wang SL; Tam MF; Ho YS; Pai SH; Kao MC
    Biochim Biophys Acta; 1995 Feb; 1260(3):285-93. PubMed ID: 7873602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Multidrug resistance mechanisms in cell line HL-60/VCR].
    Zhu XH; Li JY; Xia XM; Zhu MQ; Geng MJ; Chen L; Zhang JQ
    Ai Zheng; 2002 Dec; 21(12):1310-3. PubMed ID: 12520737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactive oxygen species-specific mechanisms of drug resistance in paraquat-resistant acute myelogenous leukemia sublines.
    Choi CH; Kim HS; Kweon OS; Lee TB; You HJ; Rha HS; Jeong JH; Lim DY; Min YD; Kim MS; Chung MH
    Mol Cells; 2000 Feb; 10(1):38-46. PubMed ID: 10774745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of reduced growth rate in the development of drug resistance of HOB1 lymphoma cells to vincristine.
    Lee WP
    Cancer Lett; 1993 Sep; 73(2-3):105-11. PubMed ID: 8221621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.